Based on 2 analysts giving stock ratings to Bionano Genomics Inc in the past month.
In the current month, BNGO has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BNGO average Analyst price target in the last month is 5.000.
Based on analysts' estimates, BNGO EPS is projected to reach -0.490 in FY2026Q3, following reported EPS of -0.643 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.64, while Bionano Genomics IncBNGO's earnings per share (EPS) for the previous quarter was USD -0.76. EPS for the next quarter is expected at USD -0.49.